ProfileGDS4459 / ENSG00000186047
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 75% 79% 67% 78% 72% 75% 75% 72% 68% 70% 74% 66% 67% 65% 71% 80% 84% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.5475
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.879
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.2367
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.7378
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.4372
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.6275
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.8175
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.4872
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.2568
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.3670
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.5474
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.1866
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.1967
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.9665
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.571
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.8880
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.3584